Sekhar Ujwala U Eadula, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 26
- 6 carriers
- Offices
- 2
Offices
2 locations · Bay Area Community Health · 106 clinicians in this group
Looking this up.
Plans that list them
26 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Eadula’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
26 of 26 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A121680 · Current
Licensed to practise in California · since 2012 · expires 2027-08-31 · Ntr University of Health Sciences, Gandhi Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
2023
Medicare did not publish checkup rates for this clinician.
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Uses standard treatment protocols
Medicaid work
$1,605,288 in 2024
Medicaid paid $1,605,288 for 19,309 billed services this clinician did in 2024, up to 486 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 5,526 | $1,529,312 |
| Short return visit (20+ min) | 7,917 | $34,795 |
| Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | 160 | $8,570 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 40-64 years | 87 | $6,879 |
| Return visit (30+ min) | 1,412 | $6,617 |
| New patient visit (30+ min) | 476 | $4,444 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 56 | $3,920 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 16 | $2,692 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 114 | $2,560 |
| Hemoglobin A1C level | 268 | $1,557 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 189 | $1,143 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 35 | $918 |
| 2024 | 19,309 | 26 | 486 | $1,605,288 |
| 2023 | 10,030 | 19 | 337 | $1,010,471 |
| 2022 | 144 | 2 | 73 | $1,952 |
| 2019 | 15 | 1 | 15 | $0 |
| 2018 | 13 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 3,551 | $945,909 |
| Short return visit (20+ min) | 3,849 | $34,888 |
| Return visit (30+ min) | 1,226 | $16,096 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 102 | $4,368 |
| New patient visit (30+ min) | 206 | $2,976 |
| Long return visit (40+ min) | 99 | $1,846 |
| Short return visit | 240 | $1,534 |
| Hemoglobin A1C level | 211 | $833 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 18 | $554 |
| Hepatitis B vaccine (HepB), CpG-adjuvanted, adult dosage, 2 dose or 4 dose schedule, for intramuscular use | 17 | $480 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 15 | $306 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 26 | $280 |
2022
| Short return visit (20+ min) | 131 | $1,124 |
| Short return visit | 13 | $828 |
2019
| New patient visit (30+ min) | 15 | $0 |
2018
| Short return visit (20+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$85,181
Pharmacies billed $85,181 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
991 generic and fewer than 11 brand-name prescriptions · $85,181 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 11 | $9,452 | $859 |
| Myrbetriq | 11 | $6,609 | $601 |
| Levothyroxine | 64 | $1,488 | $23 |
| Gabapentin | 41 | $725 | $18 |
| Albuterol Sulfate Hfa | 21 | $609 | $29 |
See all 22 drugs
| Eliquis | 11 | $9,452 | $859 |
| Myrbetriq | 11 | $6,609 | $601 |
| Levothyroxine | 64 | $1,488 | $23 |
| Gabapentin | 41 | $725 | $18 |
| Albuterol Sulfate Hfa | 21 | $609 | $29 |
| Atorvastatin | 98 | $463 | $5 |
| Losartan | 63 | $388 | $6 |
| Lisinopril | 58 | $360 | $6 |
| Metoprolol | 17 | $353 | $21 |
| Metformin | 76 | $335 | $4 |
| Amlodipine Besylate | 67 | $298 | $4 |
| Metoprolol | 30 | $213 | $7 |
| Glipizide | 23 | $183 | $8 |
| Chlorthalidone | 18 | $179 | $10 |
| Simvastatin | 39 | $175 | $4 |
| Oxybutynin Chloride Er | 14 | $147 | $10 |
| Losartan-Hydrochlorothiazide | 15 | $115 | $8 |
| Hydralazine | 14 | $104 | $7 |
| Pravastatin | 13 | $94 | $7 |
| Fluticasone Propionate | 15 | $86 | $6 |
| Hydrochlorothiazide | 25 | $82 | $3 |
| Omeprazole | 22 | $81 | $4 |
Year by year
| 2024 | 1,103 | 212 | None | None | $85,181 |
| 2023 | 727 | 169 | None | None | $85,890 |
| 2022 | 203 | 71 | None | None | $13,331 |
| 2021 | 200 | 30 | 0% (0) | 9% | $7,106 |
| 2020 | 211 | 43 | None | 12% | $12,211 |
| 2019 | 184 | 31 | None | None | $22,692 |
| 2018 | 201 | 43 | None | 6% | $19,499 |
| 2017 | 165 | 27 | None | 20% | $9,360 |
| 2016 | 41 | 12 | None | 0% | $435 |
| 2015 | 258 | 109 | 7% (17) | None | $10,752 |
| 2014 | 102 | 81 | None | 19% | $2,271 |
| 2013 | 300 | 187 | 9% (27) | None | $7,942 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Rybelsus | 12 | $26,740 | $2,228 |
| Gabapentin | 45 | $1,625 | $36 |
| Atorvastatin | 53 | $1,597 | $30 |
| Losartan | 46 | $1,190 | $26 |
| Levothyroxine | 46 | $904 | $20 |
| Metformin | 36 | $704 | $20 |
| Amlodipine Besylate | 31 | $612 | $20 |
| Levetiracetam | 11 | $550 | $50 |
| Losartan-Hydrochlorothiazide | 13 | $374 | $29 |
| Omeprazole | 17 | $372 | $22 |
| Diclofenac | 17 | $329 | $19 |
| Metoprolol | 11 | $318 | $29 |
| Lisinopril | 20 | $274 | $14 |
| Fluticasone Propionate | 14 | $264 | $19 |
| Simvastatin | 23 | $223 | $10 |
| Atenolol | 14 | $101 | $7 |
2022: 5 drugs
| Losartan | 11 | $192 | $17 |
| Amlodipine Besylate | 11 | $189 | $17 |
| Atorvastatin | 19 | $186 | $10 |
| Lisinopril | 15 | $134 | $9 |
| Levothyroxine | 11 | $127 | $12 |
2021: 7 drugs
| Levothyroxine | 12 | $334 | $28 |
| Losartan | 25 | $334 | $13 |
| Metoprolol | 14 | $239 | $17 |
| Amlodipine Besylate | 14 | $229 | $16 |
| Atorvastatin | 16 | $216 | $14 |
| Hydrochlorothiazide | 21 | $167 | $8 |
| Lisinopril | 13 | $115 | $9 |
2020: 4 drugs
| Amlodipine Besylate | 17 | $142 | $8 |
| Losartan | 17 | $140 | $8 |
| Metformin | 11 | $93 | $8 |
| Hydrochlorothiazide | 16 | $81 | $5 |
2019: 5 drugs
| Entecavir | 12 | $1,080 | $90 |
| Losartan | 19 | $253 | $13 |
| Metformin | 15 | $148 | $10 |
| Simvastatin | 11 | $123 | $11 |
| Hydrochlorothiazide | 11 | $75 | $7 |
2018: 3 drugs
| Metoprolol | 16 | $402 | $25 |
| Losartan | 21 | $214 | $10 |
| Simvastatin | 11 | $191 | $17 |
2017: 2 drugs
| Losartan | 13 | $82 | $6 |
| Cyclobenzaprine | 12 | $56 | $5 |
2015: 1 drug
| Atorvastatin | 14 | $148 | $11 |
2014: 1 drug
| Azithromycin | 11 | $101 | $9 |
2013: 7 drugs
| Proair Hfa | 24 | $1,136 | $47 |
| Levofloxacin | 21 | $298 | $14 |
| Cephalexin | 29 | $199 | $7 |
| Azithromycin | 18 | $163 | $9 |
| Hydrocodone-Acetaminophen | 12 | $139 | $12 |
| Ciprofloxacin | 14 | $128 | $9 |
| Prednisone | 13 | $50 | $4 |
Money from drug and device companies
$73 in 2025
| 2025 | 3 | 3 | None | $73 |
| 2019 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $25 | 1 payment
|
| Seqirus USA | Fluad | $24 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $24 | 1 payment
|
See all 3 published payments
| Dynavax Technologies | Meals · 2025-06-05 | Heplisav-B | $24 |
| Seqirus USA | Meals · 2025-03-27 | Fluad | $24 |
| Pfizer | Meals · 2025-02-20 | Prevnar 20 | $25 |
See earlier years (2019)
2019: $19
| Sanofi Pasteur | Fluzone Quadrivalent | $19 | 1 payment
|
Professional record
- NPI
- 1427313345
- Licence
- CA A121680California A121680: Current · expires 2027-08-31
- Trained
- Mercy College, 2012
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 200 Jose Figueres Ave Ste 285, San Jose, CA, 95116
- NPI first listed
- 2012-07-06
- NPI last updated
- 2016-08-24
This is when the NPI record was last certified, not a medical board exam.